COSMO PHARMACEUTICALS N.V. FY 2023 Results Webcast
Cosmo invites investors, financial analysts and business/life sciences journalists to a live video webcast presentation which will follow at
Live conference call and video webcast presentation
Date: Wednesday,
Time:
Participant Link: Live Webcast
Please note that there is a function to type in your questions via webcast.
Via phone: Participants wishing to ask verbal questions via phone may call the following numbers below. To ensure prompt access, please call approximately ten minutes prior to the scheduled start of the call.
The Full-Year Report 2023 as well as the corresponding media release will be available for download as of
Replay
The webcast, along with the presentation, will be available online shortly after the event and accessible for three months.
Investor Day in
Cosmo will host an Investor Day in
Date: Wednesday,
Time:
Location:
RSVP Pre-registration link (to attend in person, deadline by Friday,
We kindly ask investors, analysts and media representatives interested in attending to pre-register via the link provided above. We look forward to welcoming you to our Investor day.
Please note that there is a function to type in your questions via webcast.
Via phone: Participants wishing to ask verbal questions via phone may call the following numbers below. To ensure prompt access, please call approximately ten minutes prior to the scheduled start of the call.
Agenda
15.00 Welcome and introduction
15:10 Company perspectives and strategy
15:40 GI Genius and Medtronic collaboration
16:10 Winlevi and Breezula updates
16.30 Clinical pipeline update
17.00 Q&A
18.00 Drinks and stand-up flying dinner
Replay
The webcast along with the presentation will be available online shortly after the event and accessible for three months.
About Cosmo
Cosmo is a pharmaceutical company focused on developing and commercializing products to treat selected gastrointestinal disorders, to improve endoscopy quality measures through aiding the detection of colonic lesions and to treat selected dermatological conditions.
Cosmo develops and manufactures products which are distributed globally by selected partners including Lialda/ Mezavant/ Mesavancol, Uceris/ Cortiment, Aemcolo/ Relafalk and Winlevi. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic for the global distribution of GI Genius which uses artificial intelligence to help detect potential signs of colon cancer. The company also has a rich development pipeline.
Contact:
Tel: +353 1 817 03 70
Email: hwinchester@cosmopharma.com
(C) 2024 Electronic News Publishing, source
